Data processing system
    1.
    发明授权
    Data processing system 失效
    数据处理系统

    公开(公告)号:US08239652B2

    公开(公告)日:2012-08-07

    申请号:US12109894

    申请日:2008-04-25

    摘要: Before arbitration is performed in an arbitration section, an access from a master is kept in a waiting state until update of a conversion table buffer is performed, and an address conversion section is provided in a subsequent stage of the arbitration section. Without waiting for the completion of buffer update, an access is issued in advance at a time when it is assured that update is completed at the completion of address conversion. Thus, influences of waiting buffer update on another master can be eliminated and access latency can be reduced.

    摘要翻译: 在仲裁部分执行仲裁之前,从主机的访问保持在等待状态,直到执行转换表缓冲器的更新,并且在仲裁部分的后续阶段提供地址转换部分。 在不等待缓冲器更新完成的情况下,在确认地址转换完成时确认更新完成时,预先发出访问。 因此,可以消除等待缓冲器更新对另一个主机的影响,并且可以减少访问延迟。

    Method and treatment using 1-methylcarbapenem derivatives as an anti-helicobacter pylori agent
    2.
    发明授权
    Method and treatment using 1-methylcarbapenem derivatives as an anti-helicobacter pylori agent 失效
    使用1-甲基碳青霉烯类衍生物作为抗幽门螺旋杆菌药物的方法和治疗

    公开(公告)号:US06180621B2

    公开(公告)日:2001-01-30

    申请号:US09187680

    申请日:1998-11-06

    IPC分类号: A01N4300

    摘要: A method for the prophylaxis or treatment of infectious diseases caused by helicobacter pyloir, by administering a pharmacologically effective amount of a 1-methoylcarbapenem coumpund of formula (I) or a pharmacologically acceptable salt or ester thereof: R1 represents a group of the following formula: R2 is a hydrogen atom or a C1-C6 alkyl group, and R3 is a hydrogen atom or a C1-C6 alkyl group.

    摘要翻译: 一种预防或治疗由幽门螺杆菌引起的感染性疾病的方法,通过施用药理学有效量的式(I)的1-甲基碳代青霉烯聚糖或其药理学上可接受的盐或酯:R1代表下式的基团: R2是氢原子或C1-C6烷基,R3是氢原子或C1-C6烷基。

    1- Methylcarbapenem derivatives
    3.
    发明授权
    1- Methylcarbapenem derivatives 失效
    1-甲基碳青霉烯衍生物

    公开(公告)号:US6090802A

    公开(公告)日:2000-07-18

    申请号:US95925

    申请日:1998-06-12

    IPC分类号: C07D477/20 A61K31/409

    CPC分类号: C07D477/20

    摘要: A 1-methylcarbapenem compound represented by the following formula (I): ##STR1## wherein R.sup.1 represents hydrogen or C.sub.1 -C.sub.4 alkyl; R.sup.2 represents hydrogen or an ester residue; and A represents a group of the formula (A1) ##STR2## wherein n is 0, 1 or 2, P is 0, 1 or 2, R.sup.3 is hydrogen or C.sub.1 -C.sub.4 alkyl and R.sup.4 is a group (Q2) ##STR3## wherein B is phenylene, phenylene(C.sub.1 -C.sub.3)alkyl, cyclohexylene, cyclohexylene(C.sub.1 -C.sub.3)alkyl or C.sub.1 -C.sub.5 alkylene, R.sup.7 is hydrogen or C.sub.1 -C.sub.4 alkyl, and R.sup.14 is a group --C(.dbd.NH)R.sup.8, wherein R.sup.8 is hydrogen or C.sub.1 -C.sub.4 alkyl or a group --NR.sup.9 R.sup.10, wherein R.sup.9 and R.sup.10 are the same or different and are hydrogen or C.sub.1 -C.sub.4 alkyl; or a pharmacologically acceptable salt thereof.

    摘要翻译: 由下式(I)表示的1-甲基碳青霉烯化合物:其中R1表示氢或C1-C4烷基; R2代表氢或酯残基; 并且A表示式(A1)的基团,其中n为0,1或2,P为0,1或2,R3为氢或C1-C4烷基,R4为基团(Q2),其中B为亚苯基,亚苯基 (C1-C3)烷基,亚环己基,亚环己基(C1-C3)烷基或C1-C5亚烷基,R7是氢或C1-C4烷基,R14是基团-C(= NH)R8,其中R8是氢或C1 -C4烷基或-NR9R10基团,其中R9和R10相同或不同,为氢或C1-C4烷基; 或其药理学上可接受的盐。